Shimadzu Corp
TSE:7701
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/B
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Price to Book (P/B) ratio compares a company`s market value to its book value. It shows how much investors are paying for each dollar of net assets on the balance sheet.
Valuation Scenarios
If P/B returns to its 3-Year Average (2.6), the stock would be worth ¥4 702.38 (31% upside from current price).
| Scenario | P/B Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 2 | ¥3 594 |
0%
|
| 3-Year Average | 2.6 | ¥4 702.38 |
+31%
|
| 5-Year Average | 2.8 | ¥5 241.89 |
+46%
|
| Industry Average | 1.4 | ¥2 572.49 |
-28%
|
| Country Average | 1.4 | ¥2 599.23 |
-28%
|
Forward P/B
Today’s price vs future total equity
Peer Comparison
| Market Cap | P/B | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
|
Shimadzu Corp
TSE:7701
|
1T JPY | 2 | 18.3 | |
| JP |
|
Keyence Corp
TSE:6861
|
15.3T JPY | 4.4 | 34.4 | |
| US |
|
Keysight Technologies Inc
NYSE:KEYS
|
59.6B USD | 9.6 | 62 | |
| CN |
|
Hangzhou Hikvision Digital Technology Co Ltd
SZSE:002415
|
306.9B CNY | 3.7 | 20.5 | |
| US |
|
Teledyne Technologies Inc
NYSE:TDY
|
30B USD | 2.8 | 32.2 | |
| SE |
|
Hexagon AB
STO:HEXA B
|
274.2B SEK | 2.1 | 12.5 | |
| CN |
|
Zhonghang Electronic Measuring Instruments Co Ltd
SZSE:300114
|
192.9B CNY | 78.1 | 1 890.2 | |
| TW |
|
Chroma ATE Inc
TWSE:2360
|
821.8B TWD | 25.8 | 70.3 | |
| UK |
|
Halma PLC
LSE:HLMA
|
16.8B GBP | 8.4 | 48.2 | |
| CN |
|
Huagong Tech Co Ltd
SZSE:000988
|
118.3B CNY | 10.7 | 80.4 | |
| US |
|
Trimble Inc
NASDAQ:TRMB
|
15.9B USD | 2.7 | 37.4 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.1 |
| Median | 1.4 |
| 70th Percentile | 2.1 |
| Max | 31 732 017.6 |
Other Multiples
Shimadzu Corp
Glance View
Founded in 1875 in Kyoto, Japan, Shimadzu Corporation has developed from a small workshop into a powerhouse of innovation in the fields of analytical and measuring instrumentation. With roots tracing back to Genzo Shimadzu's dedication to craftsmanship and technological progress, the company began its journey focusing on educational physics and chemistry apparatus. Over the years, Shimadzu embraced this core philosophy to expand into diverse industries, effectively transforming itself into a significant player in areas such as life sciences, industrial testing, and environmental analysis. Their entrance into the production of X-ray equipment in the early 1900s marked a pivotal shift, cementing their position as pioneers and ensuring a steady stream of revenue through innovation and specialization. Today, Shimadzu's business strategy lies in leveraging its expertise in scientific technology to create high-quality products that serve various global markets. The company designs and manufactures analytical instruments like chromatographs, spectrometers, and DNA sequencers, which are vital in academic research, pharmaceuticals, and environmental studies. The healthcare sector, for instance, is a significant revenue driver, with Shimadzu providing a range of medical equipment that supports diagnostic and therapeutic procedures. Moreover, their industrial division offers testing and inspection machines crucial for quality assurance in sectors like automotive and aerospace. Through sustained research and development, along with strategic partnerships, Shimadzu ensures a competitive edge and continuous growth in its diverse product lines. This broad yet focused approach not only fortifies its market presence but also ensures its financial success across multiple industries.